Tofacitinib for the Treatment of Pyoderma Gangrenosum

被引：53

作者：

Kochar, Bharati ^{[1
,2
]}

Herfarth, Neel ^{[3
]}

Mamie, Celine ^{[3
]}

Navarini, Alexander A. ^{[4
,5
]}

Scharl, Michael ^{[3
]}

Herfarth, Hans H. ^{[1
,2
]}

机构：

[1] Univ N Carolina, Multidisciplinary Ctr Inflammatory Bowel Dis, Chapel Hill, NC 27599 USA

[2] Univ N Carolina, Div Gastroenterol & Hepatol, Bioinformat Bldg,CB 7080, Chapel Hill, NC 27599 USA

[3] Univ Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland

[4] Univ Hosp, Dept Dermatol, Zurich, Switzerland

[5] Univ Zurich, Zurich, Switzerland

来源：

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 17卷 / 05期

关键词：

D O I：

10.1016/j.cgh.2018.10.047

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：991 / 993

页数：3

共 8 条

[1] Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial [J].

Bachelez, Herve ;

van de Kerkhof, Peter C. M. ;

Strohal, Robert ;

Kubanov, Alexey ;

Valenzuela, Fernando ;

Lee, Joo-Heung ;

Yakusevich, Vladimir ;

Chimenti, Sergio ;

Papacharalambous, Jocelyne ;

Proulx, James ;

Gupta, Pankaj ;

Tan, Huaming ;

Tawadrous, Margaret ;

Valdez, Hernan ;

Wolk, Robert .

LANCET, 2015, 386 (9993) :552-561

[2] JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects [J].

Banerjee, Shubhasree ;

Biehl, Ann ;

Gadina, Massimo ;

Hasni, Sarfaraz ;

Schwartz, Daniella M. .

DRUGS, 2017, 77 (05) :521-546

[3] JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines [J].

Danese, Silvio ;

Grisham, Matthew ;

Hodge, Jennifer ;

Telliez, Jean-Baptiste .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2016, 310 (03) :G155-G162

[4] Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis [J].

Hanauer, Stephen ;

Panaccione, Remo ;

Danese, Silvio ;

Cheifetz, Adam ;

Reinisch, Walter ;

Higgins, Peter D. R. ;

Woodworth, Deborah A. ;

Zhang, Haiying ;

Friedman, Gary S. ;

Lawendy, Nervin ;

Quirk, Daniel ;

Nduaka, Chudy I. ;

Su, Chinyu .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) :139-147

[5] Successful therapy for pyoderma gangrenosum with a Janus kinase 2 inhibitor [J].

Nasifoglu, S. ;

Heinrich, B. ;

Welzel, J. .

BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) :504-505

[6] Pyoderma Gangrenosum: A Review for the Gastroenterologist [J].

Plumptre, Isabella ;

Knabel, Daniel ;

Tomecki, Kenneth .

INFLAMMATORY BOWEL DISEASES, 2018, 24 (12) :2510-2517

[7] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis [J].

Sandborn, William J. ;

Su, Chinyu ;

Sands, Bruce E. ;

D'Haens, Geert R. ;

Vermeire, Severine ;

Schreiber, Stefan ;

Danese, Silvio ;

Feagan, Brian G. ;

Reinisch, Walter ;

Niezychowski, Wojciech ;

Friedman, Gary ;

Lawendy, Nervin ;

Yu, Dahong ;

Woodworth, Deborah ;

Mukherjee, Arnab ;

Zhang, Haiying ;

Healey, Paul ;

Panes, Julian .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18) :1723-1736

[8] Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy [J].

Scharl, Michael ;

Mwinyi, Jessica ;

Fischbeck, Anne ;

Leucht, Katharina ;

Eloranta, Jyrki J. ;

Arikkat, Joba ;

Pesch, Theresa ;

Kellermeier, Silvia ;

Mair, Alma ;

Kullak-Ublick, Gerd A. ;

Truninger, Kaspar ;

Noreen, Faiza ;

Regula, Jaroslaw ;

Gaj, Pawel ;

Pittet, Valerie ;

Mueller, Christoph ;

Hofmann, Claudia ;

Fried, Michael ;

McCole, Declan F. ;

Rogler, Gerhard .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) :900-912

← 1 →